Article

Targeted diphtheria toxin to treat BPDCN

Blood
DOI: 10.1182/blood-2014-06-578633
25Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this issue of Blood, Frankel et al describe a novel treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) using an engineered version of diphtheria toxin that is targeted to malignant cells via a fusion with interleukin (IL)3 (see panel A).

Cite

CITATION STYLE

APA

FitzGerald, D. J. (2014, July 17). Targeted diphtheria toxin to treat BPDCN. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-06-578633

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free